PFM Health Sciences, LP
Position in CGEM — Cullinan Therapeutics, Inc.
CIK 1442756
SAN FRANCISCO, CA
Position in CGEM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,504,368
+$272,929 QoQ
Shares Held
192,442
-15.4% QoQ
Ownership
0.299%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#44
of 183 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CGEM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PFM Health Sciences, LP holds $494,895,363 across 45 Biotechnology names. CGEM ranks #35 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
233,171 | $62,191,369 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
219,596 | $53,750,512 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
160,768 | $38,740,264 | |
| 4 | INBX |
Inhibrx Biosciences, Inc.
|
308,385 | $29,219,478 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
143,222 | $26,822,616 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
253,358 | $18,870,103 | |
| 7 | CYTK |
Cytokinetics Inc
|
191,686 | $16,329,730 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
29,313 | $15,739,615 |
All Filings in CGEM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,504,368 | 192,442 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,231,439 | 227,406 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,349,481 | 227,003 | Shares | Defined | 2026-02-17 | |
| 2024-09-30 | $3,060,239 | 182,810 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,162,867 | 296,036 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,361,677 | 255,967 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||